![Matthew Brams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Brams
Oprichter bij
CINGULATE INC.
Vermogen: 44 619 $ op 30-06-2026
Profiel
Matthew N.
Brams is the founder of Cingulate, Inc., founded in 2012, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is the founder of Cingulate Works, Inc., founded in 2013, where the title held is Chief Medical Officer & Executive Vice President.
Dr. Brams is also the founder of Cingulate Therapeutics LLC..
Dr. Brams is currently Clinical Associate Professor at Baylor College of Medicine.
Formerly, Medical Director & Principal at Bayou City Research, Inc. from 1999 to 2021.
Education includes undergraduate degree from The University of Texas at Austin and doctorate from The University of Texas Health Science Center at Houston.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CINGULATE, INC. 0,06% | 16-07-2026 | 8.157 ( 0,06% ) | 44 619 $ | 30-06-2026 |
Actieve functies van Matthew Brams
| Bedrijven | Functie | Begin |
|---|---|---|
| CINGULATE INC. | Oprichter | 01-05-2012 |
Cingulate Therapeutics LLC
 Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Oprichter | - |
Cingulate Works, Inc.
 Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Oprichter | 01-01-2013 |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Eerdere bekende functies van Matthew Brams
| Bedrijven | Functie | Einde |
|---|---|---|
Bayou City Research, Inc. | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 |
Opleiding van Matthew Brams
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on develops attention deficit/hyperactivity disorder products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas Health Science Center at Houston
 The University of Texas Health Science Center at Houston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for the treatment of central nervous system and neurobiological disorders | Health Technology |
Cingulate, Inc.
 Cingulate, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bayou City Research, Inc. |
